Possible involvement of G-CSF in IgA nephropathy developing in an allogeneic peripheral blood SCT donor.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

1. Crescentic transformation induced by granulocyte-colony stimulating factor administration-a case report and review of the literature.Clinical kidney journal · 2026
   Article
2. IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration.CEN case reports · 2023
   Article
3. Cyclic neutropenia and concomitant IgA nephropathy: a case report.BMC nephrology · 2023
   Article
4. Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening.Bone marrow transplantation · 2016
   Article
5. Relapsing acute kidney injury associated with pegfilgrastim.Case reports in nephrology and urology · 2012
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

7 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as